Publication | Open Access

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

Zoledronic AcidFinal 60-Month ResultsOncologyBreast OncologyCancer ManagementGynecologyBreast CancerPharmacotherapyMedicineWomen's HealthZo-fast Study